| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
PGR antisense RNA 1 | 0.514 | 0.808 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2012 | 2012 | |||||||||
|
mitotic arrest deficient 2 like 2 | 0.547 | 0.731 | 8.2E-02 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2017 | 2017 | ||||||||
|
RNA, 7SL, cytoplasmic 263, pseudogene | 0.496 | 0.808 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | |||||||||
|
COPI coat complex subunit alpha | 0.700 | 0.385 | 1.00 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2010 | 2010 | ||||||||
|
iodothyronine deiodinase 2 | 0.590 | 0.731 | 0.62 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
growth differentiation factor 2 | 0.529 | 0.731 | 2.5E-03 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2018 | 2018 | ||||||||
|
hypocretin receptor 1 | 0.623 | 0.654 | 1.7E-04 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2017 | 2017 | ||||||||
|
solute carrier family 29 member 2 | 0.653 | 0.577 | 3.2E-14 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2005 | 2005 | ||||||||
|
heat shock protein family A (Hsp70) member 1A | 0.486 | 0.769 | 3.0E-02 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2010 | 2010 | ||||||||
|
heat shock protein family A (Hsp70) member 1B | 0.474 | 0.808 | 5.3E-03 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2010 | 2010 | ||||||||
|
kallikrein related peptidase 3 | 0.443 | 0.885 | 4.4E-06 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2020 | 2020 | ||||||||
|
MDM4 regulator of p53 | 0.461 | 0.808 | 1.00 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2017 | 2017 | ||||||||
|
CAP-Gly domain containing linker protein 1 | 0.617 | 0.654 | 0.68 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2004 | 2004 | ||||||||
|
ATP binding cassette subfamily G member 8 | 0.573 | 0.538 | 2.4E-20 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2013 | 2013 | ||||||||
|
secretory leukocyte peptidase inhibitor | 0.449 | 0.846 | 9.0E-04 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2018 | 2018 | ||||||||
|
microRNA 33b | 0.601 | 0.615 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2014 | 2014 | |||||||||
|
transferrin receptor | 0.437 | 0.885 | 7.0E-05 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2018 | 2018 | ||||||||
|
CAP-Gly domain containing linker protein 2 | 0.529 | 0.808 | 1.00 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2004 | 2004 | ||||||||
|
activin A receptor like type 1 | 0.493 | 0.769 | 9.7E-04 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2018 | 2018 | ||||||||
|
forkhead box N3 | 0.686 | 0.538 | 0.93 |
|
disease | 0.020 | None | 0.500 | 2 | 1 | 2018 | 2019 | ||||||||
|
cholinergic receptor muscarinic 3 | 0.464 | 0.885 | 0.99 |
|
disease | 0.020 | None | 0.500 | 2 | 1 | 2011 | 2019 | ||||||||
|
angiotensin II receptor type 2 | 0.496 | 0.808 | 8.2E-03 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2012 | 2019 | ||||||||
|
apolipoprotein M | 0.590 | 0.769 | 9.6E-04 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2003 | 2015 | ||||||||
|
C-C motif chemokine ligand 5 | 0.403 | 0.885 | 1.8E-03 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2008 | 2018 | ||||||||
|
nucleotide binding oligomerization domain containing 2 | 0.423 | 0.923 | 2.0E-30 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2015 | 2017 |